Found "Health Policies": 1,019 results
Wanrudee Isaranuwatchai, PhD
Dr. Wanrudee Isaranuwatchai is a Secretary General and Senior Researcher of the Health Intervention and Technology Assessment Program Foundation (HITAP), Thailand. She is also an Affiliated Scientist at St. Michael’s Hospital, and an Associate Professor at the Institute of Health Policy, Management and Evaluation, University of Toronto, in Canada.H
Telemedicine utilization patterns and implications amidst covid-19 outbreaks in Thailand under public universal coverage scheme
Abstract
During COVID-19 pandemic, telemedicine was a strategy to facilitate healthcare service delivery minimizing the risk of direct exposure among people. In Thailand, the National Health Security Office has included telemedicine services under the Universal Coverage Scheme to support social d
Prototype Development for an Integrated Health Impact Assessment Framework
โรคเบาหวานและภาวะแทรกซ้อนของโรคเบาหวาน เป็นปัญหาสาธารณสุขที่สำคัญระดับโลก ผู้ป่วยเบาหวานทั่วโลกที่มีอายุระหว่าง 20 – 79 ปี ม
Economic evaluation of an integrated care on delaying chronic kidney disease progression in rural communities of Thailand
In Thailand, the prevalence of chronic kidney disease (CKD) is 17.5% of the population (Ingsathit et al., 2010). According to Thailand’s National Health Security Office (2021), in each year, this public health agency spends approximately 10,000 million Baht in renal dialysis and 1,000 million Baht for the CKD treatment and other related expenses.
The Lancet Commission for Strengthening the Use of Epidemiological Modelling of Emerging and Pandemic Infectious Diseases
Epidemiological modelling is an important tool to help public health planners understand potential disease outcomes in the population. The recent visibility of models and their perceived influence in the decision-making processes surrounding the response to the COVID-19 pandemic has led to a great d
Kidney Replacement Therapy Policy of Universal Care Scheme in Thailand: Lessons Learned and The Way Forward
Kidney failure (KF)[1] is a life-threatening disease that requires either kidney transplantation or dialysis for survival (1, 2). As of 2019, it was estimated that globally, 1.4 million deaths occurred on account of chronic kidney disease (CKD) (3). The cost of treatment for KF is also high, leading to catastrophic household expenditure to househo
Health Cost of Modifiable Risk Factors in Thailand Phase 2
Diseases are caused by a range of risk factors, some of which are modifiable risk factors. Understanding the health cost burden associated with each modifiable risk factor can provide valuable insights for the health system, such as helping prioritize public health interventions that target the most harmful risk factors or designing programs that c
Early Health Technology Assessment of Non-sputum-based Assays for Screening and Treatment Monitoring in a prospective cohort of pulmonary tuberculosis
66261068HM025L0Early Health Technology Assessment,pulmonary tuberculosis
Prototype Development for a Health Impact Assessment Framework
ปัจจุบัน ประชากรโลกกำลังเผชิญกับการเปลี่ยนแปลงทางโครงสร้างประชากร โดยเฉพาะการเพิ่มขึ้นของสัดส่วนผู้สูงอายุและการลดลงขอ
10 / Page